New combination treatment flips the switch on melanoma cells
Think of the protein BH3 like a finger that turns off a cancer cell survival switch. The problem is that […]
» Read moreOrganic foods have become increasingly popular over the last decade. A 2018 study conducted by the Organic Trade Association found […] Patient studies of a new sensing device have proved it can provide early warning of the potential failure of breast […] Bowel cancer rates are on the rise in younger people across Europe ‘due to poor diets, obesity and sedentary lifestyles’ […] MONDAY, Oct. 22, 2018 — For patients with metastatic triple-negative breast cancer, atezolizumab plus nanoparticle albumin-bound (nab)-paclitaxel prolongs progression-free survival […] Immunotherapy on its own is better than aggressive chemotherapy as a first-line treatment for advanced head and neck cancer, according […] Diabetes is characterized by persistent high blood sugar levels that occur when certain cells in the pancreas — the insulin-producing […] Researchers from The Ottawa Hospital and the University of Ottawa have developed a promising targeted strategy to treat chemotherapy-resistant acute […] Treating the prostate with radiotherapy alongside standard treatment led to an 11 per cent increase in survival for some men […] Adjuvant treatment with the bone sparing drug zoledronic acid plus hormonal therapy with the aromatase inhibitor letrozole significantly increases disease-free […]
Can Eating Organic Foods Lower Your Cancer Risk? It's Complicated
New wireless device can aid recovery of breast cancer patients
Bowel cancer rates are on the rise in younger people across Europe
Chemoimmunotherapy Ups Survival in Triple-Negative Breast Cancer
Immunotherapy effective as first-line treatment for advanced head and neck cancer
Cells that change jobs to fight diabetes
New drug combination destroys chemo-resistant blood cancer
Cancer trial shows treating the prostate with radiotherapy improves survival
Zoledronic acid improves disease-free survival in premenopausal HR+ early breast cancer
